Senesco Technologies (SNTI -3.3%) appoints Ronald A. Martell as CEO replacing acting CEO Vaughn V. Smider, M.D., Ph.D. who will remain CSO. Mr. Martell's previous job was President and CEO of NeurogesX. Prior to that, he was CEO of Poniard Pharmaceuticals.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs